ORN

Over the past six months, Orion Group Holdings, Inc.'s stock experienced a significant drop of 24.14% on July 28, 2026, following its second-quarter 2026 earnings report, where it missed Wall Street estimates for adjusted earnings and revenue, attributing the weaker performance to timing delays in its marine business. On October 8, 2026, the company announced its third-quarter 2026 financial results would be reported on October 27, 2026, with a conference call on October 28, 2026, leading to a slight stock decline. A passive investor reported holding 2.16 million shares of ORN on October 9, 2026. The company announced conference participation on September 22, 2026, and May 18, 2026. On August 4, 2026, VivaMed BioPharma announced its Board of Directors, which was noted in ORN news without specified direct impact. The stock saw a +3.89% movement on April 28, 2026. On March 3, 2026, Orion Group Holdings reported its fourth-quarter and full-year 2025 results, initiated its 2026 financial guidance, and highlighted the acquisition of J.E. McAmis in February 2026.